Less Ads, More Data, More Tools Register for FREE

Pin to quick picks96ES.L Regulatory News (96ES)

  • There is currently no data for 96ES

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2016 EU-wide stress test results

1 Aug 2016 07:00

RNS Number : 7580F
Barclays PLC
30 July 2016
 

 

29 July 2016

 

Barclays PLC

 

2016 EU-wide stress test results

 

Barclays was subject to the 2016 EUwide stress test conducted by the European Banking Authority (EBA), in cooperation with the Bank of England (BoE), the European Central Bank (ECB), the European Commission (EC) and the European Systemic Risk Board (ESRB).

 

Barclays notes the announcements made on 29 July 2016 by the EBA on the EUwide stress test. The stress test results in a reduction of Barclays CRD IV Fully Loaded Common Equity Tier 1 ("CET1") ratio to 7.3% from the 2015 year-end position of 11.4%. The 2016 EUwide stress test does not contain a pass fail threshold.

 

The adverse stress test scenario was set by the ECB/ESRB and covers a threeyear time horizon (20162018). The stress test has been carried out applying a static balance sheet assumption as at December 2015, and therefore does not take into account subsequent or future business strategies and management actions. It is not a forecast of Barclays' profits.

 

While the results of the exercise will constitute an input to the 2016 supervisory review process, Barclays' capital requirements to cover against stress risks will primarily be informed by the BoE stress test, which is due to be published later this year.

 

Barclays' 30 June 2016 CET1 ratio was 11.6%, and Barclays remains comfortable with its target of building the ratio further to maintain a 100-150bps CET1 buffer above future regulatory CET1 levels. Barclays' 30 June 2016 CET1 ratio of 11.6% would provide a stress buffer of c.4% above the 2016 BoE stress test systemic reference point. Barclays intends to maintain a buffer around these levels in end-state.

 

Barclays' Euro-denominated results in the EBA template can be found at www.barclays.com/barclays-investor-relations/investor-news.html. The standardised disclosure templates have been developed by the EBA to help improve comparability and consistency between the stress test results of participating banks. The templates include detailed information on composition of capital, profit and loss, credit risk, sovereign exposures, securitisations, risk weighted assets and non-performing/forborne exposures.

 

 

- Ends -

 

For further information, please contact:

 

Investor Relations Media Relations

Kathryn McLeland Tom Hoskin

+44 (0) 20 7116 4943 + 44 (0) 20 7116 6927

 

 

 

 

 

Notes to editors:

 

The 2016 EU-wide stress test is a constrained bottom-up exercise that provides banks with a common methodology and templates to project in a consistent way the impact of common scenarios. The adverse scenario stresses banks' consolidated balance sheet and income statement over 36 months from 31 December 2015, based on assumptions determined by the EBA. Among other things, these assumptions are calculated based on 2011-15 balance sheets and income statements, apply caps and floors, do not allow for management actions, and in certain respects do not take account of impacts resulting from banks undertaking meaningful restructuring and exits of business activities.

 

About Barclays

 

Barclays is a transatlantic consumer, corporate and investment bank offering products and services across personal, corporate and investment banking, credit cards and wealth management, with a strong presence in our two home markets of the UK and the US.

 

With over 325 years of history and expertise in banking, Barclays operates in over 40 countries and employs approximately 130,000 people. Barclays moves, lends, invests and protects money for customers and clients worldwide.

 

For further information about Barclays, please visit our website home.barclays

 

INFORMATION REGARDING FORWARD-LOOKING STATEMENTS

 

 

This announcement contains forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Barclays group. These statements are based on the current beliefs and expectations of Barclays' management and are subject to significant risks and uncertainties. Actual outcomes may differ materially from those expressed in the forward-looking statements. Factors that could impact Barclays' future financial condition and performance are identified in our filings with the Securities and Exchange Commission ("SEC") (including, without limitation, our Annual Report on Form 20-F for the fiscal year ended 31 December 2015) which are available on the SEC's website (www.sec.gov). Subject to Barclays' obligations under the applicable laws and regulations of the United Kingdom and the United States in relation to disclosure and ongoing information, Barclays does not undertake to update the forward-looking statements to reflect the impact of circumstances or events that may arise after the date of the forward-looking statements.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDLIFVEDSIIVIR
Date   Source Headline
30th Mar 20217:00 amRNSResults of placing in Gamma Communications
29th Mar 20214:47 pmRNSProposed placing in Gamma Communications
16th Mar 20217:00 amRNSResults of placing in Wizz Air
15th Mar 20214:44 pmRNSProposed placing in Wizz Air
9th Mar 20215:25 pmRNSFCA Combined Supplement 2 of 2020
18th Feb 20216:25 pmRNSAnnual Report on Form 20-F
18th Feb 202110:47 amRNSFCA Supplement 1_2020 Barclays Bank Ireland BP16
18th Feb 202110:46 amRNSFCA Supplement 2_2020_Barclays Bank Ireland BP9
18th Feb 202110:39 amRNSFCA Combined Supplement 1_2020 - RNS Announcement
18th Feb 20217:00 amRNSAnnual Financial Report
17th Feb 20217:00 amRNSResults of placing in Hargreaves Lansdown
16th Feb 20214:41 pmRNSProposed placing in Hargreaves Lansdown
29th Jan 20213:16 pmRNSPublication of Suppl.Prospcts
15th Jan 20214:42 pmRNSNotice to Holders of Results of Adjourned Meeting
7th Jan 20213:45 pmRNSFinal Result of Tender Offer to Noteholders
21st Dec 20203:45 pmRNSResult of Tender Offer to Noteholders
16th Dec 20206:27 pmRNSNotice to Security Holders of Results of Meetings
16th Dec 20206:27 pmRNSNotice of Security Holders Adjourned Meetings
16th Dec 20206:26 pmRNSNotice to Security Holders of Results of Meetings
9th Dec 20203:31 pmRNSPublication of a Prospectus
7th Dec 20205:52 pmRNSTender Offer to Noteholders
24th Nov 20201:45 pmRNSAmendment - Notice to holders of Securities
23rd Nov 20207:37 amRNSNotice to holders of outstanding Securities
5th Oct 202010:28 amRNSPost Stab- Commerzbank AT1 No Stabilisation Notice
1st Oct 20207:00 amRNSDirectorate Change
15th Sep 20207:00 amRNSResults of placing in Watches of Switzerland Group
14th Sep 20204:50 pmRNSProposed placing in Watches of Switzerland Group
8th Sep 20208:23 amRNSPre-Stabilisation Notice - Commerzbank AT1
28th Aug 20207:00 amRNSNotice of Redemption
26th Aug 20205:24 pmRNSPublication of BP2 pursuant to the GSSP
12th Aug 202011:36 amRNSArticle 8
12th Aug 202011:10 amRNSArticle 8
7th Aug 202010:50 amRNSPublication of Suppl.Prospcts
29th Jul 20207:00 amRNSHalf-year Report
17th Jul 20202:59 pmRNSPost Stabilisation Notice Exxon - no stabilisation
17th Jul 202011:32 amRNSAnnouncement of Partial Redemption
30th Jun 20202:20 pmRNSPublication of 2020 GSSP Base Prospectus 16
26th Jun 20202:23 pmRNSArticle 8
23rd Jun 20203:06 pmRNSExxon Pre-Stabilisation Notice
22nd Jun 202010:22 amRNSArticle 8
19th Jun 20204:51 pmRNSArticle 8
12th Jun 202012:56 pmRNSBarclays PLC Post Stabilisation Notice
20th May 20205:11 pmRNSArticle 8
15th May 20204:51 pmRNSPublication of Suppl.Prospcts
15th May 20202:32 pmRNSBarclays PLC T2 Pre-Stabilisation Notice
14th May 20203:22 pmRNSArticle 8
12th May 202011:00 amRNSDoc re. rights attached to debt securities
4th May 20204:45 pmRNSPublication of a Prospectus
6th Apr 20205:18 pmRNSDelisting Notice
31st Mar 20201:05 pmRNSNotice to Noteholders Series 11492 Class MV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.